ClinicalTrials.Veeva

Menu

Effect of Probiotics After Neurosurgery (ProSURG)

U

University Maribor

Status

Enrolling

Conditions

Healing

Treatments

Dietary Supplement: OMNi-BiOTiC® Hetox multistrain probiotic
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT07200518
UKC-MB-KME-38/24

Details and patient eligibility

About

The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC® Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery.

The main question it aims to answer is:

• Is the multistrain probiotic OMNi-BiOTiC® Hetox effective in in improving patient-reported disability after neurosurgery?

Researchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.

Enrollment

110 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adults with MRI-confirmed disc herniation, stenosis, or instability of the lumbar or cervical spine.
  • Able to provide written informed consent
  • Willing to comply with study procedures and follow-up assessments
  • No contraindications to probiotic administration

Exclusion criteria

  • symptoms of acute infection (vomiting, fever above 38°C, diarrhea, respiratory symptoms),
  • chronic diseases,
  • use of probiotics one month before inclusion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

110 participants in 2 patient groups, including a placebo group

Probiotic
Experimental group
Description:
Lacticaseibacillus casei W56 Lactobacillus acidophilus W37 Levilactobacillus brevis W63 Lactococcus lactis W58 Lactococcus lactis W19 Bifidobacterium lactis W52 Ligiactobacillus salivarius W24 Bifidobacterium lactis W51 Bifidobacterium bifidum W23 corn starch, maltodextrin, plant protein, potassium chloride, magnesium sulphate, amylase manganese sulphate
Treatment:
Dietary Supplement: OMNi-BiOTiC® Hetox multistrain probiotic
Placebo
Placebo Comparator group
Description:
corn starch, maltodextrin, plant protein, potassium chloride, magnesium sulphate, amylase manganese sulphate
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

SABINA FIJAN, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems